Massachusetts-based Moderna will likely be the first to manufacture a bird flu vaccine, backed by hundreds of millions in government funding. The biopharmaceutical giant is developing the vaccine as a ...

Moderna wins EU tender to supply COVID-19 vaccines for up to four years, offering diverse formats like prefilled syringes to ...

Moderna (MRNA) stock gained in the premarket after the company received a tender to supply its COVID-19 vaccine in the EU, ...

Discover how scientists developed a COVID-19 vaccine in record time using mRNA technology, leading to improved public health ...

As Moderna (NASDAQ: MRNA) looks to shore up its business in the wake of its declining coronavirus vaccine sales, it's natural ...

Representatives of Moderna Biotech UK and NHS England will also be questioned by the inquiry, led by crossbench peer Baroness ...

Robert F. Kennedy Jr. made claims during his Senate confirmation hearing on issues including vaccines, pesticides and Lyme ...

Fla., praised news that President Donald Trump will reinstate service members expelled for refusing to take the COVID-19 ...

The Agreement provides participating countries with the opportunity to diversify their mRNA COVID-19 vaccine supply and gain access to pre-filled syringe vaccine formats CAMBRIDGE, MA / ACCESS ...

Moderna (MRNA) announced that it has been awarded a tender for the supply of its mRNA COVID-19 vaccine in the European Union, Norway and North ...

Moderna received a $590 million award from the U.S. government to speed development of a vaccine that could be used to fight bird flu.

The early stage company is developing a new approach to gene editing to treat rare genetic diseases. It does this using mRNA, ...